O’Reilly has a strong presence in the consumer market and provides us with a great opportunity to offer titles to many who might not otherwise see our content – all in a DRM-free format. That’s a win for both companies.
Waltham, MA (PRWEB) April 16, 2013
Elsevier, a world-leading provider of scientific, technical and medical information products and services, and technology publisher O'Reilly Media today announced that O'Reilly will distribute many of Elsevier¹s academic, research-focused ebooks. This expands the depth of ebooks available from O’Reilly in areas such as computer security and networking, and includes leading imprints such as Morgan Kaufmann, Syngress, Academic Press, Butterworth-Heinemann, Newnes and Elsevier with more than 1,200 individual titles.
“The consumer ebook market is an emerging and changing one and we want to offer customers as many choices as possible,” stated Suzanne BeDell, Managing Director of Elsevier’s Science & Technology Books. “O’Reilly has a strong presence in the consumer market and provides us with a great opportunity to offer titles to many who might not otherwise see our content – all in a DRM-free format. That’s a win for both companies.”
Elsevier ebooks purchased through oreilly.com are offered DRM-free and are available in multiple formats, including PDF, EPUB, and .MOBI. Free ebook updates are also guaranteed, along with lifetime access.
"We're honored to be working with Elsevier," said Pascal Honscher, O'Reilly's General Manager for Corporate Development. "Elsevier’s impressive selection of titles includes some of the most trusted imprints in tech publishing. Their reputation within the scientific community is unparalleled and the quality of their content is superb."
“The alignment of digital content philosophies is an important part of the mix. Working with a publisher that shares and embraces similar ideals is particularly gratifying," Honscher continued. "We're thrilled to offer Elsevier's ebooks to readers already gathered within the O'Reilly community."
To learn more, visit http://www.oreilly.com.
# # #
Note for Editors
For more information or to request an interview, please contact Sara Peyton at peyton(at)oreilly(dot)com. Books are available to credentialed journalists upon request; contact Michelle McMahon at +1 781 663 2268 or m.mcmahon.1(at)elsevier(dot)com to request a review copy or to schedule an interview with an author.
O'Reilly Media spreads the knowledge of innovators through its books, online services, magazines, and conferences. Since 1978, O'Reilly Media has been a chronicler and catalyst of cutting-edge development, homing in on the technology trends that really matter and spurring their adoption by amplifying "faint signals" from the alpha geeks who are creating the future. An active participant in the technology community, the company has a long history of advocacy, meme-making, and evangelism.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).